Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Protective Immune Response
100%
Ferret
100%
Plant-derived
100%
VLP Vaccine
100%
H7N9 Influenza Virus
100%
Humoral Response
50%
Alum
50%
Vaccine Adjuvant
33%
Adjuvanted
33%
H7N9
33%
Single Immunization
33%
Vaccine Response
33%
Cellular Immunity
16%
Virus
16%
Immune Response
16%
Preventive Vaccine
16%
Immunogenicity
16%
Vaccination
16%
Placebo
16%
Lung
16%
Human Infection
16%
Case Fatality Rate
16%
Immunogenic
16%
Influenza Virus
16%
Centers for Disease Control
16%
Disease Prevention
16%
Clinical Signs
16%
Lethal Challenge
16%
CMI Response
16%
Influenza
16%
Viral Load
16%
Severe Acute
16%
Pandemic Virus
16%
Protective Response
16%
Acute Respiratory Distress Syndrome
16%
% Protection
16%
Hemagglutinin
16%
Two-dose
16%
March 2013
16%
Asymptomatic Infection
16%
Nasal Wash
16%
CD3+ T Cells
16%
Severe Pneumonia
16%
Response-ability
16%
GLA-SE
16%
Rapid Production
16%
No Weight Loss
16%
Anhui
16%
Plant-made
16%
Hangzhou
16%
Antigen-specific Activation
16%
Immunology and Microbiology
Immune Response
100%
Mustela Putorius Furo
100%
Influenza A Virus (H7N9)
100%
Infectious Disease
66%
Infection
66%
Humoral Immunity
33%
Virus
33%
Adoptive Immunity
16%
T Cell
16%
Immunogenicity
16%
Antigen Specificity
16%
Influenza
16%
Case Fatality Rate
16%
Viral Load
16%
Influenza Virus
16%
Hemagglutinin
16%
CD3 Antigen
16%
Aves
16%
Lung
16%